Neurofibroma
Watchlist
Retrieved
2022-04-26
Source
Trials
—
Genes
NF1,
SUZ12,
KIT,
NF2,
SPRED1,
CDKN2A,
PDGFB,
TP53,
SUFU,
SMARCB1,
SDHC,
SDHB,
EGFR,
S100B,
PDGFRA,
S100A1,
MDK,
NRG1,
EGF,
SMUG1,
VEGFA,
FGF2,
MDM2,
SOX9,
PDGFRB,
CCND1,
FN1,
TOP2A,
BRAF,
CDKN2B-AS1
NF1,
SUZ12,
KIT,
NF2,
SPRED1,
CDKN2A,
PDGFB,
TP53,
SUFU,
SMARCB1,
SDHC,
SDHB,
EGFR,
S100B,
PDGFRA,
S100A1,
MDK,
NRG1,
EGF,
SMUG1,
VEGFA,
FGF2,
MDM2,
SOX9,
PDGFRB,
CCND1,
FN1,
TOP2A,
BRAF,
CDKN2B-AS1,
STAT3,
CTNNB1,
SST,
EED,
HMGA2,
SYK,
CNTN2,
FGF23,
VDR,
TGFA,
AURKA,
NKX2-1,
CXCR4,
WT1,
TLE1,
TGFB1,
ALDH1A1,
RGS6,
SPRY1,
H3P23,
TMED7-TICAM2,
CCR2,
MIR339,
MIR34A,
MIR210,
MIR21,
MIR10B,
TICAM2,
GADL1,
THSD7A,
AZIN2,
ARID1B,
ADAP2,
TMED7,
CD274,
PDCD4,
BRD4,
KANK1,
SNF8,
DCTN6,
ZNRD2,
CIB1,
NES,
PTN,
SOAT1,
DCX,
GHSR,
GEM,
FOLH1,
MLANA,
EZH2,
EVI2B,
ERBB2,
EPHB2,
EFNA3,
DUSP5,
CSF1,
GSTP1,
COL3A1,
CNP,
CDKN2B,
CDKN1B,
CDK4,
CD44,
CD38,
RUNX1,
ATRX,
ATM,
CXCR3,
HGF,
SMARCA2,
PPARD,
CXCL12,
CCL2,
RASA1,
PTPN11,
AR,
PTEN,
PSMD9,
MAPK3,
MAPK1,
PRKAR1A,
PMP22,
IFI27,
PLG,
PGR,
PDGFA,
SERPINE1,
NGF,
MVD,
MMP13,
LEP,
CXCL10,
IFNA2,
H3P10
Drugs
—
Registered!
A neurofibroma is a non-cancerous (benign) tumor that develops from the cells and tissues that cover nerves. Some people who develop neurofibromas have a genetic condition known as neurofibromatosis (NF). There are different types of NF, but type 1 is the most common.